GLYCODX Trademark

Trademark Overview


On Friday, October 16, 2015, a trademark application was filed for GLYCODX with the United States Patent and Trademark Office. The USPTO has given the GLYCODX trademark a serial number of 86790734. The federal status of this trademark filing is REGISTERED as of Tuesday, October 16, 2018. This trademark is owned by OBI PHARMA, INC.. The GLYCODX trademark is filed in the Pharmaceutical Products category with the following description:

amino acids for medical purposes; biological preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; blood for medical purposes; blood plasma; capsules sold empty for pharmaceuticals; chemical reagents for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; detergents for medical purposes; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; drugs for medical purpose, namely, pharmaceutical preparations for the treatment of...
glycodx

General Information


Serial Number86790734
Word MarkGLYCODX
Filing DateFriday, October 16, 2015
Status700 - REGISTERED
Status DateTuesday, October 16, 2018
Registration Number5583190
Registration DateTuesday, October 16, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements


Goods and Servicesamino acids for medical purposes; biological preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; blood for medical purposes; blood plasma; capsules sold empty for pharmaceuticals; chemical reagents for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; detergents for medical purposes; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; drugs for medical purpose, namely, pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases; pharmaceutical preparations for treatment of immune system related diseases, cancer and infectious diseases; reagent paper for medical purposes; medicated serums for treatment of immune system related diseases, cancer and infectious diseases; sugar for medical purposes; vaccines; Anti-cancer preparations; Biological preparations for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and antiangiogenic therapy; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for using in oncology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 21, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOBI PHARMA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTaipei City 115011
TW

Party NameOBI PHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei City 115 R.O.C.
TW

Party NameOBI PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 115 R.O.C.
TW

Trademark Events


Event DateEvent Description
Wednesday, March 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 27, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, March 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 27, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 27, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 16, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 16, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 22, 20181(B) BASIS DELETED; NEW BASIS REQUESTED
Friday, June 22, 2018NOTICE OF ALLOWANCE CANCELLED
Thursday, June 21, 2018ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Thursday, June 21, 2018PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, June 21, 2018ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Thursday, June 21, 2018PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, June 12, 2018TEAS RESPONSE TO PETITION INQUIRY LETTER
Monday, June 4, 2018PETITION INQUIRY LETTER ISSUED
Friday, June 1, 2018ASSIGNED TO PETITION STAFF
Tuesday, May 1, 2018PAPER RECEIVED
Friday, April 27, 2018TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, March 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 26, 2018SOU EXTENSION 3 GRANTED
Monday, March 26, 2018SOU EXTENSION 3 FILED
Monday, March 26, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, February 20, 2018ASSIGNED TO EXAMINER
Friday, October 6, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 4, 2017SOU EXTENSION 2 GRANTED
Wednesday, October 4, 2017SOU EXTENSION 2 FILED
Wednesday, October 4, 2017SOU TEAS EXTENSION RECEIVED
Friday, March 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 8, 2017SOU EXTENSION 1 GRANTED
Wednesday, March 8, 2017SOU EXTENSION 1 FILED
Wednesday, March 8, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, October 25, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 30, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 21, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 19, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 19, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 14, 2016ASSIGNED TO LIE
Friday, July 8, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 8, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 8, 2016NON-FINAL ACTION E-MAILED
Monday, February 8, 2016NON-FINAL ACTION WRITTEN
Monday, February 8, 2016ASSIGNED TO EXAMINER
Wednesday, October 21, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 20, 2015NEW APPLICATION ENTERED